Pradaxa Wrongful Death Lawyers Reviewing Cases Nationwide

Internal bleeding and other serious complications caused by side effects of Pradaxa has resulted in hundreds of reported deaths worldwide.

Contact Our Lawyers About a PRADAXA LAWSUIT

  • This field is for validation purposes and should be left unchanged.

*By submitting, you authorize Saiontz & Kirk, P.A. to send text messages to the numbers provided, including information & offers, possibly using automated technology. Message/data rates apply. Consent is not a condition for acceptance of services.
Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD

Following a Pradaxa settlement announced in May 2014, the lawyers at Saiontz & Kirk, P.A. the lawyers at Saiontz & Kirk, P.A. are continuing to review new wrongful death cases for individuals who died after taking this new-generation anticoagulant.

Financial compensation may be available through a Pradaxa wrongful death lawsuit as a result of the drug makers failure to properly researched the risk of bleeding complications or warn about the potentially fatal health problems, including:

  • Internal Bleeding
  • Gastrointestinal (GI) Bleeds
  • Hemorrhages
  • Strokes

Saiontz & Kirk, P.A. is also investigating potential Xarelto wrongful death lawsuits for individuals who suffered similar bleeding problems after using this similar blood thinner.

To review whether you or a loved one may be entitled to financial compensation, request a free consultation and case evaluation.


Pradaxa (dabigatran) was introduced by Boehringer Ingelheim in October 2010 as a revolutionary blood thinner for prevention of strokes among patients suffering from atrial fibrillation. However, the medication has also been widely used “off-label” as an anticoagulant for other purposes that have not been established as safe or effective by the FDA.

Boehringer Ingelheim introduced and marketed Pradaxa as a replacement for Coumadin (warfarin), indicating that it was a superior medication because it requires less monitoring.

However, Pradaxa bleeds can not be counteracted with a dose of Vitamin K, like Coumadin. As a result, it appears that there is an increased risk of serious bleeding and death from Pradaxa.

In the short time the medication has been on the market, a shocking number of Pradaxa deaths have been reported and it has quickly become one of the most dangerous medications in the United States.

During the first quarter of 2011, the FDA received adverse event reports indicating that at least 120 people died on Pradaxa and more than 500 people experienced complications with hemorrhage or bleeds. This far surpassed the number of problems reported in association with warfarin (or Coumadin), which is a much older and more widely used medication.


The loss of a loved one can have a devastating impact on the surviving spouse, parents and children.

Through a wrongful death lawsuit over Pradaxa, compensation was available for the financial and emotional damages caused by the drug maker’s decision to place profits before consumer safety by providing inadequate warnings and failing to issue a Pradaxa recall as soon as it became apparent that the medication carries an unreasonable risk of death.